Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
- 1Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India
- 2Department of Chemistry, Akshara First Grade College, Bengaluru, India
- 3GenLab Biosolutions Private Limited, Bangalore, Karnataka, India
- 4Department of Biomedical Sciences, School of Life Sciences, Anglia Ruskin University, Cambridge, United Kingdom
- 5School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
- 6Solution Chemistry of Advanced Materials and Technologies (SCAMT) Institute, ITMO University, St. Petersburg, Russia
- 7Department of Food Science and Technology, Graphic Era Deemed to be University, Dehradun, Uttarakhand, India
- 8Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India
- 9Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, India
- 10Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, India
Citation: Thakur N, Quazi S, Naik B, Jha SK and Singh P (2023) New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics. Front. Oncol. 13:1193736. doi: 10.3389/fonc.2023.1193736
Received: 25 March 2023; Accepted: 18 July 2023;
Published: 17 August 2023; Retracted: 07 December 2023.
Edited by:
Qing Kay Li, Johns Hopkins Medicine, United StatesReviewed by:
Rintu Thomas, Baylor College of Medicine, United StatesXuxu Gou, University of California, San Francisco, United States
Marzia Di Donato, University of Campania Luigi Vanvitelli, Italy